How is TB-500 administered?
This describes how TB-500 is typically administered in clinical and research references, not a self-administration guide. The usual route is Subcutaneous or intramuscular, on a loading 2x/wk → maintenance 1x/wk schedule, generally over 8-12 weeks total. Specific dosing is individual and beyond general information, and human evidence for TB-500 is limited.
Administration at a glance (reference data)
- Route: Subcutaneous or intramuscular
- Schedule: Loading 2x/wk → maintenance 1x/wk
- Cycle length: 8-12 weeks total
- Half-life: ~2-3 days
References
- Thymosin β4: a novel regenerative pharmacological agent — Goldstein AL & Kleinman HK, Ann NY Acad Sci, 2012
- Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair — Bock-Marquette I, Saxena A, White MD, Dimaio JM, Srivastava D — Nature, 2004
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on TB-500
Last updated 2026-06-15.